Bernd J. Krause
Holger Crafoord Str. 26
Hechingen, BW 72379, Germany
Hechingen, BW 72379, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 263 publications
Update to "Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy".
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 16, 2026
FDG PET Hybrid Imaging.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Published: May 21, 2026
No evidence of major integrative brain clearance impairment in an Alzheimer´s disease model of transgenic APPswe/PS1dE9 mice.
Journal: Fluids and barriers of the CNS
Published: May 20, 2026
Targeting pancreatic cancer with combined inhibition of EGFR and RAF.
Journal: PloS one
Published: September 18, 2025
Minor neuropsychological deficits and stage 2 of Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: August 22, 2025
O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial.
Journal: The Lancet. Oncology
Published: August 19, 2025
Corrigendum to "Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial" [Eur. Urol. 86 (2024) 552-562].
Journal: European urology
Published: April 09, 2025
Inconsistent primary motor cortex glucose hypometabolism in primary lateral sclerosis.
Journal: Journal of neurology
Published: January 03, 2025
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 29, 2024
Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice.
Journal: Molecular metabolism
Published: December 27, 2024
Rethinking Dosimetry: A European Perspective.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 21, 2024
Case report: Behavioral variant FTD confounding a language variant FTD in a case of PSP-CBS.
Journal: Frontiers in dementia
Published: December 05, 2024
Last Updated: 09/26/2026